Cargando…

Time on drug analysis based on real life data

INTRODUCTION: The health condition of HIV-1 infected patients has improved during the last years, but lifelong antiretroviral treatment is still needed. However resistance, multiple side effects and drug to drug interactions of antiretrovirals challenge the establishment of a long lasting regimen. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schülter, Eugen, Kaiser, Rolf, Zazzi, Maurizio, Sönnerborg, Anders, Camacho, Ricardo, Verheyen, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P258
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225363/ https://www.ncbi.nlm.nih.gov/pubmed/25397534 http://dx.doi.org/10.7448/IAS.17.4.19790

Ejemplares similares

Evaluation of the effect of the COVID-19 crisis on sexual health in Egypt: An online national survey with the collaboration of the I-SHARE (International Sexual Health And REproductive Health) survey
por: Shaeer, O, et al.
Publicado: (2022)

Statut vaccinal chez les patients hospitalisés pour COVID-19 durant la 3(e) vague : étude transversale aux chapiteaux de réanimation COVID-19 de la région de Marrakech
por: Abdala, S., et al.
Publicado: (2022)

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA
por: Bianco, Claudia, et al.
Publicado: (2014)

Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequences
por: Pironti, Alejandro, et al.
Publicado: (2014)

Longitudinal comparison of HIV-1 plasma viral load and cellular proviral load
por: Schweitzer, Finja, et al.
Publicado: (2014)

Time trends in HIV-1 transmitted drug resistance mutation frequency in Poland
por: Parczewski, Milosz, et al.
Publicado: (2014)

Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. Interim analysis (24 weeks). COINFECOVA-SEICV study
por: Minguez, Carlos, et al.
Publicado: (2014)

Quality of life of people living with HIV, preliminary results from IANUA (Investigation on Antiretroviral Therapy) study
por: Venturini, Alberto, et al.
Publicado: (2014)

Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone
por: Garimella, Tushar, et al.
Publicado: (2014)

Selecting anti-HIV therapies based on a variety of genomic and clinical factors
por: Rosen-Zvi, Michal, et al.
Publicado: (2008)

No difference in persistence to treatment with atazanavir or darunavir in HIV patients in a real-world setting
por: Farr, Amanda M, et al.
Publicado: (2014)

Real-world medication persistence with single versus multiple tablet regimens for HIV-1 treatment
por: Sweet, Donna, et al.
Publicado: (2014)

Recreational drugs and HIV in Europe: current use of recreational drugs and principal HIV guidelines related recommendations
por: Garin Escriva, Noe, et al.
Publicado: (2014)

Potential drug–drug interactions in HIV-perinatally infected adolescents on antiretroviral therapy in Buenos Aires, Argentina
por: Cordova, Ezequiel, et al.
Publicado: (2014)

Results from a national treatment database – does it matter which ART combination is prescribed in the real world?
por: Scott, Gordon, et al.
Publicado: (2014)

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe
por: Mocroft, Amanda, et al.
Publicado: (2014)

Severe birth defects in children perinatal exposed to HIV from a “real-world” setting: Infectious Diseases National Institute, Bucharest, Romania
por: Maria Tudor, Ana
Publicado: (2014)

Hidden costs of HIV treatment in Spain: inefficiency of the antiretroviral drug packaging
por: Llibre-Codina, Josep M, et al.
Publicado: (2014)

Safety of darunavir/ritonavir (DRV/r) in HIV-1-infected DRV/r-experienced and -naïve patients: analysis of data in the real-world setting in Italy
por: Antinori, Andrea, et al.
Publicado: (2014)

Comparison of Classifier Fusion Methods for Predicting Response to Anti HIV-1 Therapy
por: Altmann, André, et al.
Publicado: (2008)

Primary drug resistance at diagnosis of HIV-1 infection: a Portuguese cohort
por: Rocha Pereira, Nuno, et al.
Publicado: (2014)

Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI
por: Maria Bottani, Giulia, et al.
Publicado: (2014)

Time to virologic failure for patients taking their first antiretroviral regimen and the subsequent resistance profiles
por: Crouzat, Frederic, et al.
Publicado: (2014)

Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013
por: McFaul, Katie, et al.
Publicado: (2014)

Transmitted antiretroviral drug resistance mutations in newly diagnosed HIV-1 positive patients in Turkey
por: Sayan, Murat, et al.
Publicado: (2014)

Co-infections and co-morbidities among injecting drug users versus sexually infected patients in Bucharest
por: Manea, Eliza, et al.
Publicado: (2014)

Long-term effect of a four-drugs induction regimen for patients with high baseline viral load
por: Maggiolo, Franco, et al.
Publicado: (2014)

The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons
por: Pietraszkiewicz, Ewa, et al.
Publicado: (2014)

Alarming increase in tuberculosis and hepatitis C virus (HCV) among HIV infected intravenous drug users
por: Oprea, Cristiana, et al.
Publicado: (2014)

Comparison of HIV-1 drug resistance profiles generated from novel software applications for routine patient care
por: Gonzalez, Dimitri, et al.
Publicado: (2014)

High frequency of antiviral drug resistance and non-b subtypes in HIV-1 patients failing antiviral therapy in Cuba
por: Kouri, Vivian, et al.
Publicado: (2014)

Transmitted drug resistance in women with intrapartum HIV-1 diagnosis: a pilot epidemiological survey in Buenos Aires, Argentina
por: Cecchini, Diego, et al.
Publicado: (2014)

Analysis of transmitted HIV-1 drug resistance using 454 ultra-deep-sequencing and the DeepChek(®)-HIV system
por: Garcia-Diaz, Ana, et al.
Publicado: (2014)

Determinants of HIV-1 drug resistance in treatment-naïve patients and its clinical implications in an antiretroviral treatment program in Cameroon
por: Zoufaly, Alexander, et al.
Publicado: (2014)

Reduced HIV symptoms and improved health-related quality of life correlate with better access to care for HIV-1 infected women: the ELLA study
por: Baran, Robert, et al.
Publicado: (2014)

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis
por: Zaccarelli, Mauro, et al.
Publicado: (2014)

Seroincidence of HIV and prevalence of transmitted drug resistance of HIV-1 strains among persons seeking voluntary counselling and testing in Taiwan
por: Liu, Wen-Chun, et al.
Publicado: (2014)

Analysis of transmitted drug resistance and HIV-1 subtypes using dried serum spots of recently HIV-infected individuals in 2013 in Germany
por: Andrea, Hauser, et al.
Publicado: (2014)

Four-drugs regimen containing raltegravir is highly effective in HIV patients starting therapy with >500,000 copies/mL viral load
por: Sterrantino, Gaetana, et al.
Publicado: (2014)

Using dried blood spots collected under field condition to determine HIV-1 diversity and drug resistance mutations in resource limited Tanzania
por: Kimaro, James, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_965skdpaocbstfjqqfams4vqm2